IOBT Archived Articles
IO Biotech: A Clinical-Stage Biotech Pioneering Immune-Modulating Therapeutic Cancer Vaccines
Published on November 30, 2024
IO Biotech, Inc. (NASDAQ:IOBT) - A Promising Immuno-Oncology Player Advancing Novel Therapeutic Cancer Vaccines
Published on September 24, 2024